Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Cash Flow for Dividends: ¥-7.9 Mil (TTM As of Mar. 2026)


SHSE:603168 Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
37 GF Score
Price ¥4.82
GF Value ¥8.67
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shapuaisi Pharmaceutical Co Cash Flow for Dividends?

Zhejiang Shapuaisi Pharmaceutical Co SHSE:603168 -4.17% 37 Cash Flow for Dividends is ¥-7.9 Mil as of Mar. 2026. GuruFocus rates SHSE:603168 with a GF Score™ of 37/100 and a GF Value™ of ¥8.67 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Zhejiang Shapuaisi Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-1.9 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-7.9 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Zhejiang Shapuaisi Pharmaceutical Co's quarterly payment of dividends declined from Sep. 2025 (¥-2.6 Mil) to Dec. 2025 (¥-1.6 Mil) but then increased from Dec. 2025 (¥-1.6 Mil) to Mar. 2026 (¥-1.9 Mil).

Zhejiang Shapuaisi Pharmaceutical Co's annual payment of dividends declined from Dec. 2023 (¥-16.3 Mil) to Dec. 2024 (¥-14.5 Mil) and declined from Dec. 2024 (¥-14.5 Mil) to Dec. 2025 (¥-7.9 Mil).

Zhejiang Shapuaisi Pharmaceutical Co Cash Flow for Dividends Related Terms

Zhejiang Shapuaisi Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shapuaisi Pharmaceutical Co Cash Flow for Dividends Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -16.25 -14.53 -7.94

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.87 -1.86 -2.58 -1.62 -1.86
SHSE:603168
37GF Score
Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Shapuaisi Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-7.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-7.9 Mil mean?
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a Cash Flow for Dividends of ¥-7.9 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zhejiang Shapuaisi Pharmaceutical Co and its competitors.
Is Zhejiang Shapuaisi Pharmaceutical Co's Cash Flow for Dividends too high?
Zhejiang Shapuaisi Pharmaceutical Co's current Cash Flow for Dividends is ¥-7.9 Mil. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Zhejiang Shapuaisi Pharmaceutical Co's Cash Flow for Dividends of ¥-7.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zhejiang Shapuaisi Pharmaceutical Co and its competitors. Zhejiang Shapuaisi Pharmaceutical Co's current Cash Flow for Dividends is ¥-7.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.67, compared to a current price of ¥4.82 — trading 44.4% below its estimated fair value. The current Cash Flow for Dividends is ¥-7.9 Mil. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current Cash Flow for Dividends is ¥-7.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥4.82 is trading 44.4% below its estimated GF Value™ of ¥8.67. GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603168:

  • Cash Flow for Dividends: ¥-7.9 Mil
  • GF Value™: ¥8.67 vs. price of ¥4.82 (44.4% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Address No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score

Get the complete analysis for SHSE:603168

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.82
Price
¥8.67
GF Value